Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA), GLP‐1 analogues, are a class of therapeutic agents used in the management of T2D that have also demonstrated cardioprotective effects in part by mitigating ceramide accumulation. Here, GCG is linked to type 2 diabetes mellitus.